期刊
PLOS ONE
卷 11, 期 2, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0148972
关键词
-
资金
- European Union [306242-NGS-PTL]
- Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH)
- Consejeria de Educacion, Junta de Castilla y Leon [HUS272U13]
- Proyectos de Investigacion del SACYL, Spain [GRS 994/A/14, BIO/SA10/14, BIO/SA31/13]
- Spanish Fondo de Investigaciones Sanitarias [FIS 09/01543, PI12/00281]
- COST Action EuGESMA [BM0801]
- Fundacion Espanola de Hematologia y Hemoterapia (FEHH)
- Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII) [RD12/0036/0069]
- Spanish Ministry of Economy and Competitiveness
- European Regional Development Fund (ERDF) Una manera de hacer Europa (Innocampus) [CEI-2010-1-0010]
- Universidad Pedagogica y Tecnologica de Colombia, Colombia [223-2011]
Identifying additional genetic alterations associated with poor prognosis in acute lymphoblastic leukemia (ALL) is still a challenge. Aims: To characterize the presence of additional DNA copy number alterations (CNAs) in children and adults with ALL by whole-genome oligonucleotide array (aCGH) analysis, and to identify their associations with clinical features and outcome. Array-CGH was carried out in 265 newly diagnosed ALLs (142 children and 123 adults). The NimbleGen CGH 12x135K array (Roche) was used to analyze genetic gains and losses. CNAs were analyzed with GISTIC and aCGHweb software. Clinical and biological variables were analyzed. Three of the patients showed chromothripsis (cth6, cth14q and cth15q). CNAs were associated with age, phenotype, genetic subtype and overall survival (OS). In the whole cohort of children, the losses on 14q32.33 (p = 0.019) and 15q13.2 (p = 0.04) were related to shorter OS. In the group of children without good-or poor-risk cytogenetics, the gain on 1p36.11 was a prognostic marker independently associated with shorter OS. In adults, the gains on 19q13.2 (p = 0.001) and Xp21.1 (p = 0.029), and the loss of 17p (p = 0.014) were independent markers of poor prognosis with respect to OS. In summary, CNAs are frequent in ALL and are associated with clinical parameters and survival. Genome-wide DNA copy number analysis allows the identification of genetic markers that predict clinical outcome, suggesting that detection of these genetic lesions will be useful in the management of patients newly diagnosed with ALL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据